Congratulations to Dr Patrick Vallance, currently President of Research and Development at GlaxoSmithKline and the Chair of COMPARE International Advisor Board. Patrick has been appointed as government Chief Scientific Adviser with effect from spring 2018.
Read the full article
Posted on Monday 13th November 2017